FDA Authorizes Rutgers Saliva Test for Coronavirus
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read MorePosted by | Apr 16, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The new saliva collection method will allow for broader population screening for covid-19 than the current method of nose and throat swabs.
Read MorePosted by | Apr 15, 2020 | Allergy & Autoimmune, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
No instrumentation or trained personnel would be needed to administer the test or to read the results.
Read MorePosted by | Apr 14, 2020 | Biochemicals & Chemical Reagents, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases, Molecular Diagnostics |
The kit is particularly suitable for total nucleic acid extraction for detecting SARS-CoV-2, the virus that causes covid-19.
Read MorePosted by | Apr 10, 2020 | Blood Banking, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases |
Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read MorePosted by | Apr 10, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The goal of the rapid test is to provide healthcare professionals with an accurate, fast, and resource-efficient method to detect coronavirus infections early.
Read More